GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
April 16, 2024 08:00 ET
|
Genetic Technologies Ltd
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
GTG Global Collaborations and Innovation Update
March 26, 2024 08:00 ET
|
Genetic Technologies Ltd
GTG Global Collaborations and Innovation Update
Laverock Therapeutics announces appointment of Ali Elsley as Finance Director and expansion of team
March 26, 2024 05:00 ET
|
Laverock Therapeutics
STEVENAGE, United Kingdom, March 26, 2024 (GLOBE NEWSWIRE) -- Laverock Therapeutics, a gene-silencing company with a uniquely powerful technology for the development of programmable advanced...
GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
March 25, 2024 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, March 25, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, “Company”, “GENE”), a global leader in guideline-driven genomics-based testing in health, wellness...
GTG to launch U.S. Customer Digital Media Sales Campaign
February 28, 2024 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, “Company”, “GTG”), is pleased to announce the launch of a wide-reaching customer – targeted...
Launching our most comprehensive test and expanding into new global markets
January 31, 2024 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE), is at the forefront in personalised predictive genomics, reshaping the healthcare landscape with...
Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement
January 05, 2024 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, “Company”) a global leader in genomics-based tests in health, wellness, and serious disease,...
GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness
December 14, 2023 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies (GTG) is proud to provide details of a series of recent transformative initiatives. Our commitment to advancing early...
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change
December 12, 2023 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and...
Tome Biosciences Launches with Over $200 Million in Funding to Advance Programmable Genomic Integration Platform
December 12, 2023 07:57 ET
|
Tome Biosciences
Tome Biosciences launches with over $200 million in funding to advance programmable genomic integration (PGI).